I too would prefer organic growth but some questions, which, shareholders are entitled to some fair and reasonable answers at the AGM.
1. What are there key growth areas or markets the company are focusing on?
2. Can they elaborate on any strategic partnerships, mergers or acquisitions under consideration?
3. Challenges facing supply chain and how the company is addressing them?
4. How they are improving operational efficiencies to meet demands, on the domestic and international markets?
5. How is the company ensuring transparent and open communication to shareholders, ie. a quarterly report would be beneficial.
Feel free to add suggestions.
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-25278
-
- There are more pages in this discussion • 153 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B |
Open | High | Low | Value | Volume |
$4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10795 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.83 | 5662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 26112 | 4.800 |
5 | 8198 | 4.790 |
4 | 2409 | 4.780 |
2 | 4629 | 4.770 |
6 | 10700 | 4.760 |
Price($) | Vol. | No. |
---|---|---|
4.840 | 6237 | 1 |
4.850 | 303 | 1 |
4.930 | 10000 | 1 |
4.950 | 2000 | 1 |
4.990 | 6521 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online